Envair Electrodyne Q1FY27 net profit up 81% YoY to ₹2.55 lakh

3 min read     Updated on 13 Aug 2026, 07:30 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Envair Electrodyne Limited reported a standalone net profit of ₹2.55 lakh for Q1FY27, down 81% YoY from ₹13.20 lakh, with nil operational revenue. Total income was ₹9.53 lakh from other sources, while expenses dropped to ₹6.07 lakh. The Board approved the sale of its Singapore investment and reappointed M.L. Bhuwania And Co LLP as statutory auditors.

powered bylight_fuzz_icon
48174222

*this image is generated using AI for illustrative purposes only.

Envair Electrodyne Limited reported a standalone net profit of ₹2.55 lakh for the quarter ended June 30, 2026, marking an 81% decline from the ₹13.20 lakh profit recorded in the corresponding quarter of FY26. The company generated total income of ₹9.53 lakh, entirely from other income, as revenue from operations remained nil. Total expenses stood at ₹6.07 lakh, down significantly from ₹21.22 lakh in the preceding quarter, primarily due to lower other expenses.

Financial Performance

The company’s financial results for Q1FY27 reflect a shift in operational focus and cost management. While revenue from operations was zero, other income contributed ₹9.53 lakh, compared to ₹9.74 lakh in Q4FY26 and ₹21.28 lakh in Q1FY26. Employee benefit expenses decreased to ₹2.80 lakh from ₹3.30 lakh in the previous quarter. Other expenses saw a sharp reduction to ₹3.27 lakh from ₹17.92 lakh in Q4FY26, contributing to the improved bottom line despite the absence of operational revenue.

Metric Q1FY27 (Unaudited) Q4FY26 (Audited) Q1FY26 (Unaudited)
Revenue from Operations - - -
Other Income ₹9.53 lakh ₹9.74 lakh ₹21.28 lakh
Total Income ₹9.53 lakh ₹9.74 lakh ₹21.28 lakh
Total Expenses ₹6.07 lakh ₹21.22 lakh ₹8.08 lakh
Profit Before Tax ₹3.45 lakh (₹11.48 lakh) ₹13.20 lakh
Net Profit ₹2.55 lakh (₹11.48 lakh) ₹13.20 lakh

Tax expense for the quarter was ₹0.90 lakh, comprising current tax of ₹0.54 lakh and deferred tax of ₹0.36 lakh. Earnings per share (basic and diluted) stood at ₹0.06, compared to a loss of ₹0.25 in the previous quarter and earnings of ₹0.28 in Q1FY26.

The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 13, 2026. The Statutory Auditors, M/s M.L. Bhuwania And Co LLP, carried out a Limited Review of the results pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company operates in a single reportable segment namely "Industrial Machinery".

What the Numbers Show

The company’s profitability in Q1FY27 is entirely dependent on non-operational income, as revenue from operations remains nil. This highlights a transitional phase where core business activities are not generating top-line growth, while cost controls have helped narrow the gap between income and expenses. The significant drop in other expenses from the previous quarter suggests potential one-time costs or restructuring efforts in Q4FY26 that are no longer impacting current results. The management is exploring new opportunities to setup a manufacturing or trading business.

Strategic Disposal of Investment

The Board approved the sale of its investment in Alliance Asia Pac Pte. Ltd., Singapore, which holds a soap manufacturing plant in Indonesia. The company will transfer 143,750 shares at USD 1.55 per share, totaling USD 222,812.50. The transaction involves two transferees:

  • Duratech Cements India Limited: Receiving 91,281 equity shares.
  • Imperial Marketing Services India Pvt. Ltd.: Receiving 52,469 equity shares.

This revised proposal supersedes an earlier plan to transfer the investment to individual promoters. The disposal is part of a strategic restructuring initiative to streamline operations and enhance shareholder value. A Postal Ballot Notice will be issued to seek fresh shareholder approval for the transaction. The entity operates under the automatic route of FEMA provisions, requiring no additional regulatory approvals.

Auditor Reappointment

The Board recommended the reappointment of M/s M.L Bhuwania And Co LLP as Statutory Auditors for a period of two years, from the conclusion of the 44th Annual General Meeting till the conclusion of the 46th Annual General Meeting. The firm, established in 1954 and converted into an LLP in 2017, has been peer-reviewed and possesses the necessary expertise for the role.

Historical Stock Returns for Envair Electrodyne

1 Day5 Days1 Month6 Months1 Year5 Years
+2.00%-5.63%-34.28%-23.90%-37.82%+41.00%

What specific timeline and milestones has management set for launching the new manufacturing or trading business to replace the nil operational revenue?

How will the proceeds from the USD 222,812 disposal of the Alliance Asia Pac investment be allocated to fund future growth initiatives?

Given the reliance on non-operational income, what is the projected trajectory for revenue from operations in Q2FY27?

Envair Electrodyne settles ₹18.47L tax TDS demand

1 min read     Updated on 28 Jul 2026, 05:33 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Envair Electrodyne Limited has resolved a tax demand of ₹18,47,440 raised by the Income Tax Department for TDS mismatches covering fiscal years 2007-08 to 2022-23. The payment was completed on July 25, 2026, following a reconciliation process that delayed disclosure until July 27, 2026. Management stated there is no material impact on operations.

powered bylight_fuzz_icon
46683990

*this image is generated using AI for illustrative purposes only.

Envair Electrodyne has settled a tax demand of ₹18,47,440 raised by the Income Tax Department regarding a TDS mismatch. The payment was made on July 25, 2026, resolving a notice originally issued on July 15, 2025. Management confirmed that the settlement carries no material impact on the company’s financials or operations. The demand covered fiscal years 2007-08 to 2022-23 and 2019-20 to 2022-23.

The disclosure was submitted under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III thereto. Anil Nagpal, Managing Director (DIN: 01302308), signed the submission to the Stock Exchange, Mumbai. The company addressed an exchange query regarding the delay in disclosure, stating that reconciliation of additional outstanding demands on the Income Tax portal caused the procedural lag. The disclosure was submitted on July 27, 2026, as the payment was made on a Saturday evening.

Transaction Details

Particulars Details
Authority Income Tax Department
Nature of Action Demand Notice issued under Income Tax Act, 1961
Violation Alleged TDS Mismatch
Date of Receipt July 15, 2025
Fiscal Years Covered FY 2007-08 to 2022-23 & FY 2019-20 to 2022-23
Amount Demanded ₹18,47,440
Date of Payment July 25, 2026
Amount Paid ₹18,47,440
Impact Assessment None; no material impact on financials or operations

What the Numbers Show

The resolution of this specific compliance matter indicates routine adherence to regulatory directives rather than a structural fiscal issue. By settling the full amount of ₹18,47,440 without reported penalties or interest accruals in the filing, Envair Electrodyne neutralizes the liability. The company noted that additional interest amounts were adjusted against unutilized balances on the TDS portal. The absence of any stated operational disruption suggests the TDS mismatch was isolated and did not affect cash flow continuity or working capital requirements during the intervening period between the notice issuance and final payment.

Historical Stock Returns for Envair Electrodyne

1 Day5 Days1 Month6 Months1 Year5 Years
+2.00%-5.63%-34.28%-23.90%-37.82%+41.00%

How might this settlement influence Envair Electrodyne's future internal controls for TDS reconciliation to prevent similar mismatches?

Could the procedural delay in disclosure raise any concerns among institutional investors regarding the company's regulatory compliance governance?

Are there any pending or potential tax audits from other jurisdictions that Envair Electrodyne needs to address following this resolution?

More News on Envair Electrodyne

1 Year Returns:-37.82%